Table 1.
Demographic, clinical, and liver histological features of 157 chronic HCV infected patients
| Features | Mean (± SD) | Minimum | Maximum |
|---|---|---|---|
| Sex (Male/Female) | 114/43 | - | - |
| Age (years) | 38.1 ± 10.2 | 19 | 58 |
| Age groups (< 40/ > 40) | 95/62 | - | - |
| Genotype (1a/3a) | 22/135 | - | - |
| Viral load (IU/ml) | 5.47 × 107 ± 1.4 × 108 | 1.7 × 104 | 1.01 × 109 |
| Hb level (g/dl) | 12.7 ± 1.3 | 10.3 | 16.7 |
| Bilirubin (mg/dl) | 1.03 ± 0.36 | 0.5 | 2.1 |
| ALT (IU/l) | 134.4 ± 63.1 | 18 | 271 |
| ALP (IU/l) | 147.7 ± 101.5 | 20 | 438 |
| AST (IU/l) | 106.7 ± 68.2 | 20 | 395 |
| Serum Albumin (g/dl) | 4.1 ± 0.31 | 3.1 | 4.9 |
| Platelet count (× 109/l) | 154.5 ± 41.7 | 49 | 229 |
| Liver fibrosis stages, n (%) | |||
| F0 | (n = 29, 18.5%) | - | - |
| F1 | (n = 39, 24.8%) | - | - |
| F0+F1 (minimal fibrosis) | (n = 68, 43.3%) | - | - |
| F2 | (n = 34, 21.7%) | - | - |
| F3 | (n = 34, 21.7%) | - | - |
| F2+F3 (advanced fibrosis) | (n = 68, 43.3%) | - | - |
| F4 (Cirrhosis) | (n = 21, 13.4%) | - | - |
| F2+F3+F4 (significant fibrosis) | (n = 89, 56.7%) | - | - |